InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: chickpea598 post# 39266

Monday, 05/22/2017 8:21:43 AM

Monday, May 22, 2017 8:21:43 AM

Post# of 48316
pIL-12 and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment (PISCES)

https://clinicaltrials.gov/ct2/show/NCT03132675?term=OncoSec+and+PISCES&rank=1


Estimated Enrollment: 48
Anticipated Study Start Date: June 1, 2017
Estimated Study Completion Date: December 1, 2019
Estimated Primary Completion Date: September 1, 2018 (Final data collection date for primary outcome measure)